Results

1–10 of 28 results for real-world

Retrospective Real-World Analysis of Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration Followed for 3 Years
Ehsan Rahimy, MD
Annual Meeting Talks
2022
Characterizing Real-World Functional Outcomes in Patients with Geographic Atrophy: An IRIS Registry Analysis
Durga Borkar, MD
Annual Meeting Talks
2022
Likelihood of Germline Mutation With Solitary Unilateral Retinoblastoma Based on Patient Age at Presentation: Real-World Analysis of 482 Consecutive Patients.
Carol L. Shields, MD
Annual Meeting Talks
2022
Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Carl J Danzig, MD
Annual Meeting Talks
2022
Automated Segmentations of Photoreceptor Degeneration and RPE loss in GA as factors to screen for fast progressors in real-world OCT data
Scott D Walter, MD, MSc, FASRS
Updates from the Field
2024
Real-World Treatment Practices Among Newly Diagnosed Patients With Noninfectious Uveitis in the United States
On Demand Cases, Courses, and Papers
2022
Real-World Results of Genetic Testing in Children at High Risk for Retinal Detachment
On Demand Cases, Courses, and Papers
2022
Long-Term Real-World Safety and Efficacy Outcomes of Intravitreal Brolucizumab in the Management of Neovascular Age-related Macular Degeneration
On Demand Cases, Courses, and Papers
2022
Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian DME Patients in a Real-World Setting: The PRECISE Study
Michel R Giunta, MD
On Demand Cases, Courses, and Papers
2021
Real-World Impact of Early Treatment With Intravitreal Dexamethasone Implant in DME in US Clinical Practice: Outcomes From the Vestrum Database
Roger A. Goldberg, MD, MBA
On Demand Cases, Courses, and Papers
2021